Status:
COMPLETED
Pharmacokinetics of Acetaminophen in Pediatric Patients With Congenital Heart Disease
Lead Sponsor:
Peter Winch
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
2-6 years
Brief Summary
This is a prospective study of pediatric patients with congenital heart disease, in which acetaminophen serum concentrations will be measured following a single intraoperative intravenous dose of acet...
Eligibility Criteria
Inclusion
- Patients presenting for Fontan palliation or for surgical repair requiring median sternotomy, will be included in the study.
- Only patients who receive intravenous acetaminophen in the operating room will have serum levels drawn.
Exclusion
- Documentation of an allergy to acetaminophen
- Severe hepatic disease or other contraindications to acetaminophen use
- Patient has received acetaminophen within 24 hours of their procedure
Key Trial Info
Start Date :
March 23 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 16 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04278625
Start Date
March 23 2021
End Date
February 16 2022
Last Update
April 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205